Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-07-01 Sale |
2021-02-12 9:51 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | GREGORY JULIA P Director |
18,000 | $71.47 | $1,286,494 | 0 (Direct) |
View |
| 2020-11-23 Purchase |
2020-11-23 8:40 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director |
5,000 | $89.55 | $447,737 | 2,526,938 (Indirect Direct) |
View |
| 2020-11-02 Sale |
2020-11-04 8:31 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
30,000 | $76.22 | $2,286,676 | 51,755 (Direct) |
View |
| 2020-10-22 Sale |
2020-10-23 9:25 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
34,969 | $79.31 | $2,773,218 | 2,545,658 (Direct) |
View |
| 2020-10-16 Sale |
2020-10-21 9:24 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
8,302 | $78.93 | $655,293 | 2,580,627 (Direct) |
View |
| 2020-10-12 Sale |
2020-10-14 9:31 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
6,729 | $78.87 | $530,740 | 2,588,929 (Direct) |
View |
| 2020-10-08 Sale |
2020-10-09 6:42 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations |
23,500 | $76.34 | $1,794,082 | 3,639 (Direct) |
View |
| 2020-09-21 Purchase |
2020-09-22 9:51 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director |
3,322 | $59.25 | $196,829 | 2,521,938 (Indirect Direct) |
View |
| 2020-09-11 Purchase |
2020-09-14 8:49 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director |
6,678 | $59 | $393,984 | 2,518,616 (Indirect Direct) |
View |
| 2020-08-11 Purchase |
2020-08-12 6:25 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director |
25,000 | $61.54 | $1,538,485 | 2,511,938 (Indirect Direct) |
View |
| 2020-07-08 Sale |
2020-07-10 9:16 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
50,000 | $75.22 | $3,760,765 | 2,595,658 (Direct) |
View |
| 2020-07-08 Sale |
2020-07-10 9:15 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Berman Robert Special Projects & Med Ovrsght |
58,404 | $75.25 | $4,394,890 | 790,891 (Indirect Direct) |
View |
| 2020-06-23 Sale |
2020-06-25 9:49 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
105,638 | $73.98 | $7,815,522 | 2,645,658 (Direct) |
View |
| 2020-06-23 Sale |
2020-06-25 9:49 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Berman Robert Special Projects & Med Ovrsght |
4,296 | $75.05 | $322,431 | 849,295 (Indirect Direct) |
View |
| 2020-06-19 Sale |
2020-06-22 9:58 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
244,362 | $71.88 | $17,565,932 | 2,751,296 (Direct) |
View |
| 2020-06-18 Sale |
2020-06-22 9:57 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Berman Robert Special Projects & Med Ovrsght |
62,300 | $75.27 | $4,689,306 | 1,042,277 (Indirect Direct) |
View |
| 2020-06-17 Sale |
2020-06-18 9:51 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations |
400 | $70.2 | $28,081 | 3,639 (Direct) |
View |
| 2020-06-17 Sale |
2020-06-17 9:55 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations |
24,000 | $70.2 | $1,684,870 | 4,039 (Direct) |
View |
| 2020-06-15 Sale |
2020-06-17 9:55 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
140,000 | $67.37 | $9,431,750 | 999,915 (Indirect Direct) |
View |
| 2020-06-12 Sale |
2020-06-12 9:51 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer |
36,966 | $64.83 | $2,396,502 | 73,427 (Indirect Direct) |
View |
| 2020-06-11 Sale |
2020-06-12 8:09 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
160,000 | $64.07 | $10,251,053 | 1,139,915 (Indirect Direct) |
View |
| 2020-06-10 Sale |
2020-06-12 5:19 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
52,000 | $67.38 | $3,504,001 | 38,062 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-07-01 Ownership |
2021-02-12 9:51 pm |
2019-05-01 2028-04-30 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | GREGORY JULIA P Director |
18,000 | $0 | 0 (Direct) |
View |
| 2020-07-01 Ownership |
2021-02-12 9:51 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | GREGORY JULIA P Director |
18,000 | $28.76 | 0 (Direct) |
View |
| 2021-01-25 Other |
2021-02-12 9:51 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director |
5,706 | $0 | 2,538,350 (Direct) |
View |
| 2021-01-06 Exercise |
2021-01-08 8:49 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
1,250 | $0 | 23,023 (Direct) |
View |
| 2021-01-06 Tax Withholding |
2021-01-08 8:49 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
492 | $83.38 | 23,023 (Direct) |
View |
| 2021-01-06 Option Award |
2021-01-08 8:49 pm |
N/A 2031-01-06 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
15,000 | $0 | 23,023 (Direct) |
View |
| 2021-01-06 Exercise |
2021-01-08 8:49 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
5,000 | $0 | 82,127 (Direct) |
View |
| 2021-01-06 Tax Withholding |
2021-01-08 8:49 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
2,124 | $83.38 | 82,127 (Direct) |
View |
| 2021-01-06 Option Award |
2021-01-08 8:49 pm |
N/A 2031-01-06 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
60,000 | $0 | 82,127 (Direct) |
View |
| 2021-01-06 Exercise |
2021-01-08 8:49 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer |
5,000 | $0 | 72,878 (Direct) |
View |
| 2021-01-06 Tax Withholding |
2021-01-08 8:49 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer |
1,747 | $83.38 | 72,878 (Direct) |
View |
| 2021-01-06 Option Award |
2021-01-08 8:49 pm |
N/A 2031-01-06 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer |
50,000 | $0 | 72,878 (Direct) |
View |
| 2021-01-06 Exercise |
2021-01-08 8:48 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations |
3,750 | $0 | 63,941 (Direct) |
View |
| 2021-01-06 Tax Withholding |
2021-01-08 8:48 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations |
1,747 | $83.38 | 63,941 (Direct) |
View |
| 2021-01-06 Option Award |
2021-01-08 8:48 pm |
N/A 2031-01-06 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations |
45,000 | $0 | 63,941 (Direct) |
View |
| 2021-01-06 Exercise |
2021-01-08 8:48 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer |
3,750 | $0 | 65,461 (Direct) |
View |
| 2021-01-06 Tax Withholding |
2021-01-08 8:48 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer |
1,747 | $83.38 | 65,461 (Direct) |
View |
| 2021-01-06 Option Award |
2021-01-08 8:48 pm |
N/A 2031-01-06 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer |
45,000 | $0 | 65,461 (Direct) |
View |
| 2021-01-06 Exercise |
2021-01-08 8:48 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer |
3,750 | $0 | 66,262 (Direct) |
View |
| 2021-01-06 Tax Withholding |
2021-01-08 8:48 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer |
1,747 | $83.38 | 66,262 (Direct) |
View |
| 2021-01-06 Option Award |
2021-01-08 8:48 pm |
N/A 2031-01-06 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer |
45,000 | $0 | 66,262 (Direct) |
View |
| 2021-01-06 Exercise |
2021-01-08 8:48 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad Chief Executive Officer |
12,500 | $0 | 1,132,039 (Direct) |
View |
| 2021-01-06 Tax Withholding |
2021-01-08 8:48 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad Chief Executive Officer |
5,802 | $83.38 | 1,132,039 (Direct) |
View |
| 2021-01-06 Option Award |
2021-01-08 8:48 pm |
N/A 2031-01-06 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad Chief Executive Officer |
150,000 | $0 | 1,132,039 (Direct) |
View |
| 2020-11-25 Exercise |
2020-11-27 9:48 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
1,250 | $0 | 5,654 (Direct) |
View |
| 2020-11-25 Tax Withholding |
2020-11-27 9:48 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
480 | $90.14 | 5,654 (Direct) |
View |
| 2020-11-25 Exercise |
2020-11-27 9:48 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer |
3,375 | $0 | 11,375 (Direct) |
View |
| 2020-11-25 Tax Withholding |
2020-11-27 9:48 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer |
1,531 | $90.14 | 11,375 (Direct) |
View |
| 2020-11-25 Exercise |
2020-11-27 9:48 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
3,000 | $0 | 9,510 (Direct) |
View |
| 2020-11-25 Tax Withholding |
2020-11-27 9:48 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
1,245 | $90.14 | 9,510 (Direct) |
View |
| 2020-11-25 Exercise |
2020-11-27 9:48 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations |
3,750 | $0 | 13,188 (Direct) |
View |
| 2020-11-25 Tax Withholding |
2020-11-27 9:48 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations |
1,701 | $90.14 | 13,188 (Direct) |
View |
| 2020-11-25 Exercise |
2020-11-27 9:47 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer |
3,700 | $0 | 13,944 (Direct) |
View |
| 2020-11-25 Tax Withholding |
2020-11-27 9:47 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer |
1,678 | $90.14 | 13,944 (Direct) |
View |
| 2020-11-25 Exercise |
2020-11-27 9:47 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad Chief Executive Officer |
10,950 | $0 | 959,000 (Direct) |
View |
| 2020-11-25 Tax Withholding |
2020-11-27 9:47 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad Chief Executive Officer |
4,965 | $90.14 | 959,000 (Direct) |
View |
| 2020-11-25 Exercise |
2020-11-27 9:47 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer |
3,000 | $0 | 13,278 (Direct) |
View |
| 2020-11-25 Tax Withholding |
2020-11-27 9:47 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer |
1,361 | $90.14 | 13,278 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-04 8:31 pm |
N/A 2029-03-31 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
30,000 | $0 | 51,755 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-04 8:31 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
30,000 | $50.72 | 51,755 (Direct) |
View |
| 2020-10-08 Exercise |
2020-10-09 6:42 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations |
23,500 | $9.29 | 3,639 (Direct) |
View |
| 2020-07-08 Exercise |
2020-07-10 9:15 pm |
N/A 2024-11-25 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Berman Robert Special Projects & Med Ovrsght |
58,404 | $0 | 790,891 (Direct) |
View |
| 2020-07-08 Exercise |
2020-07-10 9:15 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Berman Robert Special Projects & Med Ovrsght |
58,404 | $0.61 | 790,891 (Direct) |
View |
| 2020-06-23 Exercise |
2020-06-25 9:49 pm |
N/A 2024-11-25 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Berman Robert Special Projects & Med Ovrsght |
4,296 | $0 | 849,295 (Direct) |
View |
| 2020-06-23 Exercise |
2020-06-25 9:49 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Berman Robert Special Projects & Med Ovrsght |
4,296 | $0.61 | 849,295 (Direct) |
View |
| 2020-06-18 Exercise |
2020-06-22 9:57 pm |
N/A 2025-10-22 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Berman Robert Special Projects & Med Ovrsght |
61,314 | $0 | 1,042,277 (Direct) |
View |
| 2020-06-18 Exercise |
2020-06-22 9:57 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Berman Robert Special Projects & Med Ovrsght |
37,300 | $0.61 | 1,042,277 (Direct) |
View |
| 2020-06-18 Exercise |
2020-06-22 9:57 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Berman Robert Special Projects & Med Ovrsght |
25,000 | $5.6 | 1,042,277 (Direct) |
View |
| 2020-06-19 Exercise |
2020-06-22 9:57 pm |
N/A 2024-11-25 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Berman Robert Special Projects & Med Ovrsght |
986 | $75.07 | 1,042,277 (Direct) |
View |
| 2020-06-17 Exercise |
2020-06-18 9:51 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations |
400 | $5.6 | 3,639 (Direct) |
View |
| 2020-06-17 Exercise |
2020-06-17 9:55 pm |
N/A 2025-10-22 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations |
24,000 | $0 | 4,039 (Direct) |
View |
| 2020-06-17 Exercise |
2020-06-17 9:55 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations |
24,000 | $5.6 | 4,039 (Direct) |
View |
Ownership(A) |
2020-06-12 9:51 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | HUGIN ROBERT J Director |
0 | $0 | 2,900 (Direct) |
View |
| 2020-06-12 Exercise |
2020-06-12 9:51 pm |
N/A 2028-11-20 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer |
36,966 | $0 | 73,427 (Direct) |
View |
| 2020-06-12 Exercise |
2020-06-12 9:51 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer |
20,716 | $20.79 | 73,427 (Direct) |
View |
| 2020-06-12 Exercise |
2020-06-12 9:51 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer |
16,250 | $32.42 | 73,427 (Direct) |
View |
| 2020-06-09 Option Award |
2020-06-12 5:58 pm |
N/A 2030-06-09 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | HUGIN ROBERT J Director |
36,000 | $0 | 36,000 (Direct) |
View |
Ownership |
2020-06-12 5:57 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | HUGIN ROBERT J Director |
0 | $0 | 2,900 (Direct) |
View |
| 2020-06-10 Exercise |
2020-06-12 5:19 pm |
N/A 2027-01-30 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
52,000 | $0 | 38,062 (Direct) |
View |
| 2020-06-10 Exercise |
2020-06-12 5:19 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
52,000 | $9.29 | 38,062 (Direct) |
View |